Sopharma AD-BG11SOSOBT18-SOPHARMA

SOPHARMA AD (189/2023) Notification from Aleksandar Tchaoushev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.

Report no 189/2023
- 12.10.2023, 15:35
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (188/2023) Notification from Bissera Lazarova under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.

Report no 188/2023
- 12.10.2023, 15:31
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (187/2023) Notification from Rositsa Doneva under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.

Report no 187/2023
- 12.10.2023, 15:25
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (186/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 10 October 2023.

Report no 186/2023
- 12.10.2023, 15:19
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (185/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 10 October 2023.

Report no 185/2023
- 11.10.2023, 16:05
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (184/2023) Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 10 October 2023.

Report no 184/2023
- 11.10.2023, 15:55
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (183/2023) New capital of "Sopharma" AD entered in the Commercial Register

Report no 183/2023
- 06.10.2023, 16:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (182/2023) Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 of 29 September 2023.

Report no 182/2023
- 04.10.2023, 09:09
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (181/2023) Conveining Extraordinary General Meeting for 24 November 2023

Report no 181/2023
- 03.10.2023, 11:34
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (180/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 29 September 2023.

Report no 180/2023
- 03.10.2023, 09:28
- Kategoria: Biznes i finanse
- Źródło: ESPI

Relacja z konferencji „Droga do prezydencji: dyskusja o priorytetach zdrowotnych polskiej prezydencji w Radzie UE”

Instytut Spraw Społecznych (1)